Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Albisetti

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Hamostaseologie|April 25, 2019
[Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren]Hermann Eichler, Manuela Albisetti Pedroni, Susan Halimeh, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 13, 2003
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki diseaseManuela Albisetti, Anthony K C Chan, Brian W McCrindle, et al.
Hamostaseologie|May 12, 2021
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Hamostaseologie|April 6, 2021
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic diseaseCornelia Heleen van Ommen, Manuela Albisetti, Anthony K Chan, et al.
Journal of the American Heart Association|February 13, 2024
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart DiseaseManuela Albisetti, Igor Tartakovsky, Jacqueline Halton, et al.
Hamostaseologie|June 27, 2020
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia AKatharina Holstein, Manuela Albisetti, Christoph Bidlingmaier, et al.
Blood Advances|September 23, 2022
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophiliaLeonardo R Brandão, Igor Tartakovsky, Manuela Albisetti, et al.
Thrombosis and Haemostasis|August 1, 2022
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical TrialsLesley G Mitchell, Daniel Röshammar, Fenglei Huang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2019
Estimation of Nuwiq<sup>®</sup> (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field studyStefan Tiefenbacher, Manuela Albisetti, Peter Baker, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Hamostaseologie|April 25, 2019
[Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren]Hermann Eichler, Manuela Albisetti Pedroni, Susan Halimeh, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 13, 2003
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki diseaseManuela Albisetti, Anthony K C Chan, Brian W McCrindle, et al.
Hamostaseologie|May 12, 2021
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Hamostaseologie|April 6, 2021
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTHJohannes Oldenburg, Robert Klamroth, Florian Langer, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
The Edoxaban Hokusai VTE PEDIATRICS Study: An open-label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic diseaseCornelia Heleen van Ommen, Manuela Albisetti, Anthony K Chan, et al.
Journal of the American Heart Association|February 13, 2024
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart DiseaseManuela Albisetti, Igor Tartakovsky, Jacqueline Halton, et al.
Hamostaseologie|June 27, 2020
Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia AKatharina Holstein, Manuela Albisetti, Christoph Bidlingmaier, et al.
Blood Advances|September 23, 2022
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophiliaLeonardo R Brandão, Igor Tartakovsky, Manuela Albisetti, et al.
Thrombosis and Haemostasis|August 1, 2022
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical TrialsLesley G Mitchell, Daniel Röshammar, Fenglei Huang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2019
Estimation of Nuwiq<sup>®</sup> (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field studyStefan Tiefenbacher, Manuela Albisetti, Peter Baker, et al.
Pageof 8